{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:15:58Z","timestamp":1789179358644,"version":"build-2803163510"},"reference-count":69,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8,18]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Adenosine deaminase (ADA) deficiency causes \u223c13% of cases of severe combined immune deficiency (SCID). Treatments include enzyme replacement therapy (ERT), hematopoietic cell transplant (HCT), and gene therapy (GT). We evaluated 131 patients with ADA-SCID diagnosed between 1982 and 2017 who were enrolled in the Primary Immune Deficiency Treatment Consortium SCID studies. Baseline clinical, immunologic, genetic characteristics, and treatment outcomes were analyzed. First definitive cellular therapy (FDCT) included 56 receiving HCT without preceding ERT (HCT); 31 HCT preceded by ERT (ERT-HCT); and 33 GT preceded by ERT (ERT-GT). Five-year event-free survival (EFS, alive, no need for further ERT or cellular therapy) was 49.5% (HCT), 73% (ERT-HCT), and 75.3% (ERT-GT; P &amp;lt; .01). Overall survival (OS) at 5 years after FDCT was 72.5% (HCT), 79.6% (ERT-HCT), and 100% (ERT-GT; P = .01). Five-year OS was superior for patients undergoing HCT at &amp;lt;3.5 months of age (91.6% vs 68% if \u22653.5 months, P = .02). Active infection at the time of HCT (regardless of ERT) decreased 5-year EFS (33.1% vs 68.2%, P &amp;lt; .01) and OS (64.7% vs 82.3%, P = .02). Five-year EFS (90.5%) and OS (100%) were best for matched sibling and matched family donors (MSD\/MFD). For patients treated after the year 2000 and without active infection at the time of FDCT, no difference in 5-year EFS or OS was found between HCT using a variety of transplant approaches and ERT-GT. This suggests alternative donor HCT may be considered when MSD\/MFD HCT and GT are not available, particularly when newborn screening identifies patients with ADA-SCID soon after birth and before the onset of infections. This trial was registered at www.clinicaltrials.gov as #NCT01186913 and #NCT01346150.<\/jats:p>","DOI":"10.1182\/blood.2022016196","type":"journal-article","created":{"date-parts":[[2022,6,7]],"date-time":"2022-06-07T18:52:20Z","timestamp":1654627940000},"page":"685-705","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":52,"title":["Outcomes following treatment for ADA-deficient severe combined immunodeficiency: a report from the PIDTC"],"prefix":"10.1182","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4493-8757","authenticated-orcid":false,"given":"Geoffrey D. E.","family":"Cuvelier","sequence":"first","affiliation":[{"name":"1Manitoba Blood and Marrow Transplant Program, CancerCare Manitoba, University of Manitoba, Winnipeg, MB, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent R.","family":"Logan","sequence":"additional","affiliation":[{"name":"2Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4175-5728","authenticated-orcid":false,"given":"Susan E.","family":"Prockop","sequence":"additional","affiliation":[{"name":"3Stem Cell Transplant Service, Dana Farber Cancer Institute\/Boston Children\u2019s Hospital, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca H.","family":"Buckley","sequence":"additional","affiliation":[{"name":"4Duke University Medical Center, Durham, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9302-0187","authenticated-orcid":false,"given":"Caroline Y.","family":"Kuo","sequence":"additional","affiliation":[{"name":"5Division of Allergy, Immunology, Rheumatology, Department of Pediatrics, David Geffen School of Medicine, University of California, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M.","family":"Griffith","sequence":"additional","affiliation":[{"name":"6Division of Allergy, Immunology and Transplantation, National Institutes of Allergy, National Institutes of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuerong","family":"Liu","sequence":"additional","affiliation":[{"name":"2Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Yip","sequence":"additional","affiliation":[{"name":"7University of California San Francisco Benioff Children\u2019s Hospital, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Hershfield","sequence":"additional","affiliation":[{"name":"4Duke University Medical Center, Durham, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3050-2397","authenticated-orcid":false,"given":"Paul G.","family":"Ayoub","sequence":"additional","affiliation":[{"name":"8Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore B.","family":"Moore","sequence":"additional","affiliation":[{"name":"9Department of Pediatric Hematology-Oncology, Mattel Children\u2019s Hospital, University of California, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9432-3542","authenticated-orcid":false,"given":"Morna J.","family":"Dorsey","sequence":"additional","affiliation":[{"name":"7University of California San Francisco Benioff Children\u2019s Hospital, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"O\u2019Reilly","sequence":"additional","affiliation":[{"name":"10Stem Cell Transplantation and Cellular Therapy, MSK Kids, Memorial Sloan-Kettering Cancer Center, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neena","family":"Kapoor","sequence":"additional","affiliation":[{"name":"11Division of Hematology, Oncology and Blood and Marrow Transplant, Children\u2019s Hospital, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Yun","family":"Pai","sequence":"additional","affiliation":[{"name":"12Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malika","family":"Kapadia","sequence":"additional","affiliation":[{"name":"13Boston Children\u2019s Hospital, Dana-Farber Cancer Institute, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2430-911X","authenticated-orcid":false,"given":"Christen L.","family":"Ebens","sequence":"additional","affiliation":[{"name":"14Division of Pediatric Blood and Marrow Transplant and Cellular Therapy, MHealth Fairview Masonic Children\u2019s Hospital, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9402-1934","authenticated-orcid":false,"given":"Lisa R.","family":"Forbes Satter","sequence":"additional","affiliation":[{"name":"15Immunology, Allergy and Retrovirology, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri M.","family":"Burroughs","sequence":"additional","affiliation":[{"name":"16Fred Hutchinson Cancer Research Center, University of Washington, Department of Pediatrics and Seattle Children\u2019s Hospital, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Petrovic","sequence":"additional","affiliation":[{"name":"16Fred Hutchinson Cancer Research Center, University of Washington, Department of Pediatrics and Seattle Children\u2019s Hospital, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak","family":"Chellapandian","sequence":"additional","affiliation":[{"name":"17Center for Cell and Gene Therapy for Non-Malignant Conditions, Johns Hopkins All Children\u2019s Hospital, St Petersburg, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Heimall","sequence":"additional","affiliation":[{"name":"18Division of Allergy and Immunology, Children\u2019s Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine at University of Pennsylvania, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Shyr","sequence":"additional","affiliation":[{"name":"19Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Lucile Packard Children\u2019s Hospital, Stanford School of Medicine, Palo Alto, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Rayes","sequence":"additional","affiliation":[{"name":"20Primary Children\u2019s Hospital, University of Utah, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6902-0876","authenticated-orcid":false,"given":"Jeffrey J.","family":"Bednarski","sequence":"additional","affiliation":[{"name":"21Washington University, St. Louis Children\u2019s Hospital, St. Louis, MO;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2933-814X","authenticated-orcid":false,"given":"Sharat","family":"Chandra","sequence":"additional","affiliation":[{"name":"22Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children\u2019s Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanmuganathan","family":"Chandrakasan","sequence":"additional","affiliation":[{"name":"23Bone Marrow Transplantation and Immune Deficiency, Children\u2019s Hospital of Atlanta, Atlanta, GA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred P.","family":"Gillio","sequence":"additional","affiliation":[{"name":"24Children\u2019s Cancer Institute, Hackensack University Medical Center, Hackensack, NJ;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Madden","sequence":"additional","affiliation":[{"name":"25Methodist Children\u2019s Hospital of South Texas, San Antonio, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy C.","family":"Quigg","sequence":"additional","affiliation":[{"name":"26Pediatric Blood and Marrow Transplant and Cellular Therapy Program, Helen DeVos Children\u2019s Hospital, Michigan State University College of Human Medicine, Grand Rapids, MI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi H.","family":"Caywood","sequence":"additional","affiliation":[{"name":"27Nemours Children\u2019s Health, Thomas Jefferson University, Wilmington, DE;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8281-3627","authenticated-orcid":false,"given":"Blachy J.","family":"D\u00e1vila Salda\u00f1a","sequence":"additional","affiliation":[{"name":"28Division of Blood and Marrow Transplantation, Children\u2019s National Hospital, Washington, DC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"DeSantes","sequence":"additional","affiliation":[{"name":"29Division of Pediatric Hematology-Oncology & Bone Marrow Transplant, University of Wisconsin, American Family Children\u2019s Hospital, Madison, WI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesham","family":"Eissa","sequence":"additional","affiliation":[{"name":"30Division of Pediatric Hematology-Oncology-BMT, Aurora, CO;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick D.","family":"Goldman","sequence":"additional","affiliation":[{"name":"31Division of Pediatric Hematology and Oncology and Bone Marrow Transplant, University of Alabama at Birmingham, Birmingham, AL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Rozmus","sequence":"additional","affiliation":[{"name":"32British Columbia Children\u2019s Hospital, Vancouver, BC, Canada;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami J.","family":"Shah","sequence":"additional","affiliation":[{"name":"19Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Lucile Packard Children\u2019s Hospital, Stanford School of Medicine, Palo Alto, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Vander Lugt","sequence":"additional","affiliation":[{"name":"33Blood and Marrow Transplant Program, University of Michigan, Ann Arbor, MI;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica S.","family":"Thakar","sequence":"additional","affiliation":[{"name":"16Fred Hutchinson Cancer Research Center, University of Washington, Department of Pediatrics and Seattle Children\u2019s Hospital, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta E.","family":"Parrott","sequence":"additional","affiliation":[{"name":"4Duke University Medical Center, Durham, NC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caridad","family":"Martinez","sequence":"additional","affiliation":[{"name":"34Hematology\/Oncology\/BMT, Texas Children\u2019s Hospital, Baylor College of Medicine, Houston, TX;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer W.","family":"Leiding","sequence":"additional","affiliation":[{"name":"35Division of Allergy and Immunology, Johns Hopkins University, St Petersburg, FL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3489-5036","authenticated-orcid":false,"given":"Troy R.","family":"Torgerson","sequence":"additional","affiliation":[{"name":"36Allen Institute for Immunology, Seattle, WA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3030-8420","authenticated-orcid":false,"given":"Michael A.","family":"Pulsipher","sequence":"additional","affiliation":[{"name":"37Division of Pediatric Hematology and Oncology, Intermountain Primary Children\u2019s Hospital, Huntsman Cancer Institute at the University of Utah Spencer Fox Eccles School of Medicine, Salt Lake City, UT;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8335-0262","authenticated-orcid":false,"given":"Luigi D.","family":"Notarangelo","sequence":"additional","affiliation":[{"name":"38Laboratory of Clinical Immunology and Microbiology, NIAID, NIH, Bethesda, MD; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morton J.","family":"Cowan","sequence":"additional","affiliation":[{"name":"7University of California San Francisco Benioff Children\u2019s Hospital, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher C.","family":"Dvorak","sequence":"additional","affiliation":[{"name":"7University of California San Francisco Benioff Children\u2019s Hospital, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2446-6879","authenticated-orcid":false,"given":"Elie","family":"Haddad","sequence":"additional","affiliation":[{"name":"39Department of Pediatrics, Centre Hospitalier Universitaire (CHU) Sainte-Justine, University of Montreal, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6623-6276","authenticated-orcid":false,"given":"Jennifer M.","family":"Puck","sequence":"additional","affiliation":[{"name":"7University of California San Francisco Benioff Children\u2019s Hospital, San Francisco, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1840-6087","authenticated-orcid":false,"given":"Donald B.","family":"Kohn","sequence":"additional","affiliation":[{"name":"8Microbiology, Immunology & Molecular Genetics, University of California, Los Angeles, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"7786","key":"2022081815223603600_B1","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0140-6736(72)92345-8","article-title":"Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity","volume":"2","author":"Giblett","year":"1972","journal-title":"Lancet."},{"issue":"1","key":"2022081815223603600_B2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jaci.2018.08.027","article-title":"The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018)","volume":"143","author":"Dvorak","year":"2019","journal-title":"J Allergy Clin Immunol."},{"issue":"1","key":"2022081815223603600_B3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13023-018-0807-5","article-title":"Adenosine deaminase deficiency: a review","volume":"13","author":"Flinn","year":"2018","journal-title":"Orphanet J Rare Dis."},{"issue":"6","key":"2022081815223603600_B4","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/ACI.0000000000000006","article-title":"Recent advances in understanding and managing adenosine deaminase and purine nucleoside phosphorylase deficiencies","volume":"13","author":"Grunebaum","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol."},{"key":"2022081815223603600_B5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fimmu.2016.00314","article-title":"Adenosine deaminase deficiency: more than just an immunodeficiency","volume":"7","author":"Whitmore","year":"2016","journal-title":"Front Immunol."},{"issue":"7","key":"2022081815223603600_B6","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s10875-017-0433-3","article-title":"Adenosine deaminase (ADA)-deficient severe combined immune deficiency (SCID): molecular pathogenesis and clinical manifestations","volume":"37","author":"Bradford","year":"2017","journal-title":"J Clin Immunol."},{"issue":"5","key":"2022081815223603600_B7","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.jaci.2013.11.029","article-title":"Pulmonary alveolar proteinosis in adenosine deaminase-deficient mice","volume":"133","author":"Dhanju","year":"2014","journal-title":"J Allergy Clin Immunol."},{"issue":"6","key":"2022081815223603600_B8","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.jaci.2012.02.003","article-title":"Pulmonary alveolar proteinosis in patients with adenosine deaminase deficiency","volume":"129","author":"Grunebaum","year":"2012","journal-title":"J Allergy Clin Immunol."},{"issue":"3","key":"2022081815223603600_B9","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10875-012-9658-3","article-title":"Non-infectious lung disease in patients with adenosine deaminase deficient severe combined immunodeficiency","volume":"32","author":"Booth","year":"2012","journal-title":"J Clin Immunol."},{"issue":"1","key":"2022081815223603600_B10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1067\/mpd.2001.115023","article-title":"Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency","volume":"139","author":"Rogers","year":"2001","journal-title":"J Pediatr."},{"issue":"3","key":"2022081815223603600_B11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.pediatrneurol.2007.03.011","article-title":"Neurologic abnormalities in patients with adenosine deaminase deficiency","volume":"37","author":"Nofech-Mozes","year":"2007","journal-title":"Pediatr Neurol."},{"issue":"9","key":"2022081815223603600_B12","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1182\/blood-2008-04-151332","article-title":"Cognitive and behavioral abnormalities in children after hematopoietic stem cell transplantation for severe congenital immunodeficiencies","volume":"112","author":"Titman","year":"2008","journal-title":"Blood."},{"issue":"4","key":"2022081815223603600_B13","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0387-7604(96)00014-9","article-title":"Sensorineural deafness in siblings with adenosine deaminase deficiency","volume":"18","author":"Tanaka","year":"1996","journal-title":"Brain Dev."},{"issue":"2","key":"2022081815223603600_B14","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jpeds.2003.10.055","article-title":"Bilateral sensorineural deafness in adenosine deaminase-deficient severe combined immunodeficiency","volume":"144","author":"Albuquerque","year":"2004","journal-title":"J Pediatr."},{"issue":"1","key":"2022081815223603600_B15","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jaci.2018.04.029","article-title":"Neutropenia among patients with adenosine deaminase deficiency","volume":"143","author":"Kim","year":"2019","journal-title":"J Allergy Clin Immunol."},{"issue":"10","key":"2022081815223603600_B16","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood-2011-01-329359","article-title":"Myeloid dysplasia and bone marrow hypocellularity in adenosine deaminase-deficient severe combined immune deficiency","volume":"118","author":"Sokolic","year":"2011","journal-title":"Blood."},{"issue":"5","key":"2022081815223603600_B17","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/pbc.24353","article-title":"Neutropenia and myeloid dysplasia in a patient with delayed-onset adenosine deaminase deficiency","volume":"60","author":"Nomura","year":"2013","journal-title":"Pediatr Blood Cancer."},{"issue":"6","key":"2022081815223603600_B18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF02026688","article-title":"Chondroosseous dysplasia in severe combined immunodeficiency due to adenosine deaminase deficiency (chondroosseous dysplasia in ADA deficiency SCID)","volume":"21","author":"Chakravarti","year":"1991","journal-title":"Pediatr Radiol."},{"issue":"5","key":"2022081815223603600_B19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00247-012-2564-2","article-title":"Characteristic scapular and rib changes on chest radiographs of children with ADA-deficiency SCIDS in the first year of life","volume":"43","author":"Manson","year":"2013","journal-title":"Pediatr Radiol."},{"issue":"2","key":"2022081815223603600_B20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-0030-1269916","article-title":"Hyperbilirubinemia and rapid fatal hepatic failure in severe combined immunodeficiency caused by adenosine deaminase deficiency (ADA-SCID)","volume":"223","author":"K\u00fchl","year":"2011","journal-title":"Klin Padiatr."},{"issue":"21","key":"2022081815223603600_B21","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJM199605233342104","article-title":"Brief report: hepatic dysfunction as a complication of adenosine deaminase deficiency","volume":"334","author":"Bollinger","year":"1996","journal-title":"N Engl J Med."},{"issue":"6","key":"2022081815223603600_B22","doi-asserted-by":"crossref","first-page":"e876","DOI":"10.1542\/peds.2005-1068","article-title":"Cerebral lymphoma in an adenosine deaminase-deficient patient with severe combined immunodeficiency receiving polyethylene glycol-conjugated adenosine deaminase","volume":"116","author":"Kaufman","year":"2005","journal-title":"Pediatrics."},{"issue":"1","key":"2022081815223603600_B23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jpeds.2007.03.059","article-title":"Burkitt\u2019s lymphoma in a patient with adenosine deaminase deficiency-severe combined immunodeficiency treated with polyethylene glycol-adenosine deaminase","volume":"151","author":"Husain","year":"2007","journal-title":"J Pediatr."},{"issue":"3","key":"2022081815223603600_B24","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jaci.2011.10.028","article-title":"Multicentric dermatofibrosarcoma protuberans in patients with adenosine deaminase-deficient severe combined immune deficiency","volume":"129","author":"Kesserwan","year":"2012","journal-title":"J Allergy Clin Immunol."},{"key":"2022081815223603600_B25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fimmu.2018.00113","article-title":"First occurrence of plasmablastic lymphoma in adenosine deaminase-deficient severe combined immunodeficiency disease patient and review of the literature","volume":"9","author":"Migliavacca","year":"2018","journal-title":"Front Immunol."},{"issue":"24","key":"2022081815223603600_B26","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1056\/NEJM197612092952402","article-title":"Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency","volume":"295","author":"Polmar","year":"1976","journal-title":"N Engl J Med."},{"issue":"3 Pt 2","key":"2022081815223603600_B27","doi-asserted-by":"crossref","first-page":"S228","DOI":"10.1016\/S0090-1229(95)90306-2","article-title":"PEG-ADA replacement therapy for adenosine deaminase deficiency: an update after 8.5 years","volume":"76","author":"Hershfield","year":"1995","journal-title":"Clin Immunol Immunopathol."},{"issue":"2","key":"2022081815223603600_B28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/humu.1380050202","article-title":"PEG-ADA: an alternative to haploidentical bone marrow transplantation and an adjunct to gene therapy for adenosine deaminase deficiency","volume":"5","author":"Hershfield","year":"1995","journal-title":"Hum Mutat."},{"issue":"1-4","key":"2022081815223603600_B29","first-page":"93","article-title":"Enzyme replacement therapy of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase (PEG-ADA)","volume":"4","author":"Hershfield","year":"1993","journal-title":"Immunodeficiency."},{"issue":"10","key":"2022081815223603600_B30","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJM198703053161005","article-title":"Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase","volume":"316","author":"Hershfield","year":"1987","journal-title":"N Engl J Med."},{"issue":"2","key":"2022081815223603600_B31","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/cei.13420","article-title":"Comparison of elapegademase and pegademase in ADA-deficient patients and mice","volume":"200","author":"Murguia-Favela","year":"2020","journal-title":"Clin Exp Immunol."},{"issue":"2","key":"2022081815223603600_B32","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clim.2005.07.006","article-title":"Long-term efficacy of enzyme replacement therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID)","volume":"117","author":"Chan","year":"2005","journal-title":"Clin Immunol."},{"issue":"5","key":"2022081815223603600_B33","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.anai.2020.12.008","article-title":"Outcomes of 3 patients with adenosine deaminase deficiency on long-term enzyme replacement therapy","volume":"126","author":"Gans","year":"2021","journal-title":"Ann Allergy Asthma Immunol."},{"key":"2022081815223603600_B34","doi-asserted-by":"crossref","first-page":"108321","DOI":"10.1016\/j.clim.2019.108321","article-title":"Morbidity in an adenosine deaminase-deficient patient during 27\u00a0years of enzyme replacement therapy","volume":"211","author":"Grunebaum","year":"2020","journal-title":"Clin Immunol."},{"issue":"1","key":"2022081815223603600_B35","doi-asserted-by":"crossref","first-page":"e20152169","DOI":"10.1542\/peds.2015-2169","article-title":"A 24-year enzyme replacement therapy in an adenosine-deaminase-deficient patient","volume":"137","author":"Tartibi","year":"2016","journal-title":"Pediatrics."},{"issue":"6","key":"2022081815223603600_B36","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s10875-017-0421-7","article-title":"Long-term outcome of adenosine deaminase-deficient patients: a single-center experience","volume":"37","author":"Scott","year":"2017","journal-title":"J Clin Immunol."},{"issue":"3","key":"2022081815223603600_B37","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jaci.2018.08.024","article-title":"Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiency","volume":"143","author":"Kohn","year":"2019","journal-title":"J Allergy Clin Immunol."},{"issue":"4","key":"2022081815223603600_B38","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10875-017-0373-y","article-title":"How we manage adenosine deaminase-deficient severe combined immune deficiency (ADA SCID)","volume":"37","author":"Kohn","year":"2017","journal-title":"J Clin Immunol."},{"issue":"9","key":"2022081815223603600_B39","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1038\/s41409-021-01378-8","article-title":"EBMT\/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunity","volume":"56","author":"Lankester","year":"2021","journal-title":"Bone Marrow Transplant."},{"issue":"17","key":"2022081815223603600_B40","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1182\/blood-2011-12-396879","article-title":"Outcome of hematopoietic stem cell transplantation for adenosine deaminase-deficient severe combined immunodeficiency","volume":"120","author":"Hassan","year":"2012","journal-title":"Blood."},{"issue":"21","key":"2022081815223603600_B41","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMoa2027675","article-title":"Autologous ex vivo lentiviral gene therapy for adenosine deaminase deficiency","volume":"384","author":"Kohn","year":"2021","journal-title":"N Engl J Med."},{"issue":"2","key":"2022081815223603600_B42","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jaci.2020.10.020","article-title":"SCID newborn screening: what we\u2019ve learned","volume":"147","author":"Currier","year":"2021","journal-title":"J Allergy Clin Immunol."},{"issue":"5","key":"2022081815223603600_B43","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1056\/NEJMoa1401177","article-title":"Transplantation outcomes for severe combined immunodeficiency, 2000-2009","volume":"371","author":"Pai","year":"2014","journal-title":"N Engl J Med."},{"issue":"25","key":"2022081815223603600_B44","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1182\/blood-2017-05-781849","article-title":"Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study","volume":"130","author":"Heimall","year":"2017","journal-title":"Blood."},{"issue":"7","key":"2022081815223603600_B45","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1056\/NEJM199902183400703","article-title":"Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency","volume":"340","author":"Buckley","year":"1999","journal-title":"N Engl J Med."},{"issue":"3","key":"2022081815223603600_B46","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1182\/blood.V99.3.872","article-title":"Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival","volume":"99","author":"Myers","year":"2002","journal-title":"Blood."},{"issue":"5","key":"2022081815223603600_B47","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1056\/NEJMoa0805817","article-title":"Gene therapy for immunodeficiency due to adenosine deaminase deficiency","volume":"360","author":"Aiuti","year":"2009","journal-title":"N Engl J Med."},{"issue":"5577","key":"2022081815223603600_B48","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1126\/science.1070104","article-title":"Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning","volume":"296","author":"Aiuti","year":"2002","journal-title":"Science."},{"issue":"3","key":"2022081815223603600_B49","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.ymthe.2017.12.022","article-title":"Gene therapy for adenosine deaminase deficiency: a comprehensive evaluation of short- and medium-term safety","volume":"26","author":"Cicalese","year":"2018","journal-title":"Mol Ther."},{"key":"2022081815223603600_B50","author":"Therapeutics"},{"issue":"5644","key":"2022081815223603600_B51","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science."},{"issue":"9","key":"2022081815223603600_B52","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1172\/JCI35798","article-title":"Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients","volume":"118","author":"Howe","year":"2008","journal-title":"J Clin Invest."},{"issue":"9","key":"2022081815223603600_B53","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1172\/JCI35700","article-title":"Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1","volume":"118","author":"Hacein-Bey-Abina","year":"2008","journal-title":"J Clin Invest."},{"issue":"10","key":"2022081815223603600_B54","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.bbmt.2020.07.004","article-title":"Busulfan pharmacokinetics in adenosine deaminase-deficient severe combined immunodeficiency gene therapy","volume":"26","author":"Bradford","year":"2020","journal-title":"Biol Blood Marrow Transplant."},{"issue":"2","key":"2022081815223603600_B55","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jaci.2016.01.051","article-title":"Primary Immune Deficiency Treatment Consortium (PIDTC) update","volume":"138","author":"Griffith","year":"2016","journal-title":"J Allergy Clin Immunol."},{"issue":"8","key":"2022081815223603600_B56","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1007\/s10875-020-00857-9","article-title":"Adenosine deaminase (ADA)-deficient severe combined immune deficiency (SCID) in the US Immunodeficiency Network (USIDNet) Registry","volume":"40","author":"Kuo","year":"2020","journal-title":"J Clin Immunol."},{"issue":"4","key":"2022081815223603600_B57","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jaci.2013.09.044","article-title":"Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience","volume":"133","author":"Shearer","year":"2014","journal-title":"J Allergy Clin Immunol."},{"issue":"17","key":"2022081815223603600_B58","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1182\/blood-2018-03-840702","article-title":"SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery","volume":"132","author":"Haddad","year":"2018","journal-title":"Blood."},{"issue":"7","key":"2022081815223603600_B59","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1007\/s10875-013-9917-y","article-title":"The natural history of children with severe combined immunodeficiency: baseline features of the first fifty patients of the primary immune deficiency treatment consortium prospective study 6901","volume":"33","author":"Dvorak","year":"2013","journal-title":"J Clin Immunol."},{"issue":"4","key":"2022081815223603600_B60","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1086\/302054","article-title":"Adenosine deaminase deficiency: genotype-phenotype correlations based on expressed activity of 29 mutant alleles","volume":"63","author":"Arredondo-Vega","year":"1998","journal-title":"Am J Hum Genet."},{"issue":"5","key":"2022081815223603600_B61","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0952-7915(03)00104-3","article-title":"Genotype is an important determinant of phenotype in adenosine deaminase deficiency","volume":"15","author":"Hershfield","year":"2003","journal-title":"Curr Opin Immunol."},{"issue":"2","key":"2022081815223603600_B62","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1182\/blood.V61.2.341.341","article-title":"Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells","volume":"61","author":"Reisner","year":"1983","journal-title":"Blood."},{"issue":"6","key":"2022081815223603600_B63","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF00915333","article-title":"Haploidentical bone marrow transplantation for severe combined immunodeficiency disease using soybean agglutinin-negative, T-depleted marrow cells","volume":"5","author":"Cowan","year":"1985","journal-title":"J Clin Immunol."},{"issue":"14","key":"2022081815223603600_B64","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1056\/NEJM197504032921402","article-title":"Severe combined immunodeficiency and adenosine deaminase deficiency","volume":"292","author":"Parkman","year":"1975","journal-title":"N Engl J Med."},{"issue":"6","key":"2022081815223603600_B65","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1172\/JCI109259","article-title":"Adenosine deaminase deficiency: disappearance of adenine deoxynucleotides from a patient\u2019s erythrocytes after successful marrow transplantation","volume":"62","author":"Chen","year":"1978","journal-title":"J Clin Invest."},{"issue":"4","key":"2022081815223603600_B66","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jaip.2021.11.032","article-title":"Long-term clinical outcomes of severe combined immunodeficiency patients given nonablative marrow transplants","volume":"10","author":"Hardin","year":"2022","journal-title":"J Allergy Clin Immunol Pract."},{"issue":"16","key":"2022081815223603600_B67","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.3390\/jcm10163548","article-title":"Is post-transplant cyclophosphamide the new methotrexate?","volume":"10","author":"Mussetti","year":"2021","journal-title":"J Clin Med."},{"issue":"1","key":"2022081815223603600_B68","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11899-017-0364-3","article-title":"T cell-depleted and T cell-replete HLA-haploidentical stem cell transplantation for non-malignant disorders","volume":"12","author":"Bertaina","year":"2017","journal-title":"Curr Hematol Malig Rep."},{"issue":"1","key":"2022081815223603600_B69","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s10875-021-01145-w","article-title":"Long-term immune recovery after hematopoietic stem cell transplantation for ADA deficiency: a single-center experience","volume":"42","author":"Kreins","year":"2022","journal-title":"J Clin Immunol."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/140\/7\/685\/1915098\/bloodbld2022016196.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/140\/7\/685\/1915098\/bloodbld2022016196.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T15:26:07Z","timestamp":1660836367000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/140\/7\/685\/485484\/Outcomes-following-treatment-for-ADA-deficient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,18]]},"references-count":69,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,8,18]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2022016196","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,18]]}}}